Skip to content

Pulsar-18 T3 6/170/90Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Pulsar-18 T3 (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07640130446632), received between Jun 17, 2020 and Jul 8, 2020 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Positioning Failure” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Positioning Failure2

Patient problems

  • No Consequences Or Impact To Patient2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 8, 2020Positioning Failure; Positioning Failure

    THE PULSAR-18 T3 STENT SYSTEM WAS SELECTED FOR USE BUT THE STENT COULD NOT BE RELEASED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10248456 ↗
  • MalfunctionJun 17, 2020Positioning Failure; Positioning Failure

    PULSAR-18 T3 STENT SYSTEM WAS CHOSEN FOR TREATMENT OF A LESION IN A CROSS-OVER PROCEDURE. AFTER POSITIONING AT THE TARGET LESION IT WAS NOT POSSIBLE TO RELEASE THE STENT AND THE DEVICE WAS THEREFORE REMOVED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10162339 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page